4163 Stock Overview
Primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 4163 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Al-Dawaa Medical Services Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س78.70 |
| 52 Week High | ر.س121.60 |
| 52 Week Low | ر.س76.10 |
| Beta | 0.11 |
| 1 Month Change | -3.67% |
| 3 Month Change | -17.16% |
| 1 Year Change | -23.29% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0.13% |
Recent News & Updates
Al-Dawaa Medical Services Company (TADAWUL:4163) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 14
Benign Growth For Al-Dawaa Medical Services Company (TADAWUL:4163) Underpins Its Share Price
Sep 24The Returns At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Growing
Jul 29Recent updates
Al-Dawaa Medical Services Company (TADAWUL:4163) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 14Benign Growth For Al-Dawaa Medical Services Company (TADAWUL:4163) Underpins Its Share Price
Sep 24The Returns At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Growing
Jul 29Market Still Lacking Some Conviction On Al-Dawaa Medical Services Company (TADAWUL:4163)
Jun 03Al-Dawaa Medical Services' (TADAWUL:4163) Strong Earnings Are Of Good Quality
May 08Al-Dawaa Medical Services (TADAWUL:4163) Hasn't Managed To Accelerate Its Returns
Apr 05Al-Dawaa Medical Services (TADAWUL:4163) Has Some Way To Go To Become A Multi-Bagger
Dec 26Al-Dawaa Medical Services (TADAWUL:4163) Has Announced A Dividend Of SAR1.25
Sep 03Return Trends At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Appealing
Jul 13Is Al-Dawaa Medical Services Company (TADAWUL:4163) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 22Returns On Capital Signal Tricky Times Ahead For Al-Dawaa Medical Services (TADAWUL:4163)
Apr 10Some Shareholders Feeling Restless Over Al-Dawaa Medical Services Company's (TADAWUL:4163) P/E Ratio
Mar 14Is Al-Dawaa Medical Services Company (TADAWUL:4163) Trading At A 34% Discount?
Dec 08Shareholder Returns
| 4163 | SA Consumer Retailing | SA Market | |
|---|---|---|---|
| 7D | -0.4% | -0.5% | -1.1% |
| 1Y | -23.3% | -5.6% | -9.0% |
Return vs Industry: 4163 underperformed the SA Consumer Retailing industry which returned -5.6% over the past year.
Return vs Market: 4163 underperformed the SA Market which returned -9% over the past year.
Price Volatility
| 4163 volatility | |
|---|---|
| 4163 Average Weekly Movement | 3.0% |
| Consumer Retailing Industry Average Movement | 3.5% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in SA Market | 7.7% |
| 10% least volatile stocks in SA Market | 2.5% |
Stable Share Price: 4163 has not had significant price volatility in the past 3 months compared to the SA market.
Volatility Over Time: 4163's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | n/a | Mohammed Saad Al-Farraj Al-Subaie | www.al-dawaa.com.sa |
Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia. It operates through three segments: Retail, Wholesale, and Logistics. The company offers medicines, perfumes, cosmetics, beauty tools and products, and other pharmaceutical products.
Al-Dawaa Medical Services Company Fundamentals Summary
| 4163 fundamental statistics | |
|---|---|
| Market cap | ر.س6.71b |
| Earnings (TTM) | ر.س358.65m |
| Revenue (TTM) | ر.س6.19b |
18.7x
P/E Ratio1.1x
P/S RatioIs 4163 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4163 income statement (TTM) | |
|---|---|
| Revenue | ر.س6.19b |
| Cost of Revenue | ر.س3.99b |
| Gross Profit | ر.س2.19b |
| Other Expenses | ر.س1.84b |
| Earnings | ر.س358.65m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.22 |
| Gross Margin | 35.46% |
| Net Profit Margin | 5.80% |
| Debt/Equity Ratio | 43.8% |
How did 4163 perform over the long term?
See historical performance and comparisonDividends
1.6%
Current Dividend Yield59%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 16:56 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Al-Dawaa Medical Services Company is covered by 7 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Duaa AlFadda | BofA Global Research |
| Alia El Mehelmy | CI Capital Research |
| Michel Salameh | Citigroup Inc |